Molecular stratification based on gene expression profiles reveals that breast cancer can be classified as luminal A and B, HER2-enriched, basal-like, and normal-like, and that these subtypes correspond primarily to the status of ER, PR, and HER2 (Russnes et al., 2017). This evidence concerns the gene ERBB2 and breast carcinoma.